Drug Shortage Report for TEVA-SPIRONOLACTONE
| Report ID | 167212 |
| Drug Identification Number | 00613215 |
| Brand name | TEVA-SPIRONOLACTONE |
| Common or Proper name | SPIRONOLACTONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SPIRONOLACTONE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | UD100's |
| ATC code | C03DA |
| ATC description | POTASSIUM-SPARING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-18 |
| Estimated end date | 2023-02-28 |
| Actual end date | 2023-04-27 |
| Shortage status | Resolved |
| Updated date | 2023-04-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2023-04-28 | English | Compare |
| v25 | 2023-04-27 | French | Compare |
| v24 | 2023-04-27 | English | Compare |
| v23 | 2023-02-16 | French | Compare |
| v22 | 2023-02-16 | English | Compare |
| v21 | 2023-02-09 | French | Compare |
| v20 | 2023-02-09 | English | Compare |
| v19 | 2023-02-02 | French | Compare |
| v18 | 2023-02-02 | English | Compare |
| v17 | 2023-01-19 | French | Compare |
| v16 | 2023-01-19 | English | Compare |
| v15 | 2022-12-01 | French | Compare |
| v14 | 2022-12-01 | English | Compare |
| v13 | 2022-12-01 | French | Compare |
| v12 | 2022-12-01 | English | Compare |
| v11 | 2022-11-11 | French | Compare |
| v10 | 2022-11-11 | English | Compare |
| v9 | 2022-10-28 | French | Compare |
| v8 | 2022-10-28 | English | Compare |
| v7 | 2022-10-17 | French | Compare |